German registry for inflammatory bowel disease
Part of Digestive system clinical trials.
This is a long-term registry study that follows people with chronic inflammatory bowel diseases to better understand the conditions and improve care. By joining, you help researchers learn more about how these diseases affect patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease, ulcerative colitis, or a type of colitis that's hard to classify
- You do not have another stomach or bowel condition besides these
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study collects information from people diagnosed with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. By joining the registry, you help researchers learn more about these conditions and improve care.
This study is a research registry that collects information from adults receiving care for inflammatory bowel disease at UPMC. It may help researchers better understand bowel disease and improve future treatments.
Hear when a new Indeterminate Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.